Cegedim SA
PAR:CGM
Cegedim SA
PAR:CGM
Price:
14.05 EUR
-0.35%
Market Closed
Updated:
May 17, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
3.9
Current
4.7
Median
13.1
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=3.9
Enterprise Value
/
411.5m
EBITDA
104.9m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| FR |
|
Cegedim SA
PAR:CGM
|
190.8m EUR | 3.9 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
33.8B USD | 64.5 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 19.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 16.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.2B AUD | 120.5 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 12.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
5.1B USD | 25.6 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
4.6B USD | -126.4 | |
| SE |
|
Sectra AB
STO:SECT B
|
45.1B SEK | -70 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 37.9 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 264.4 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
3.6
2-Years Forward
EV/EBITDA
3.5
3-Years Forward
EV/EBITDA
3.3
You don't have any saved screeners yet
